(NASDAQ: SHC) Sotera Health Co's forecast annual revenue growth rate of 4.44% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.99%.
Sotera Health Co's revenue in 2026 is $1,229,747,000.On average, 12 Wall Street analysts forecast SHC's revenue for 2026 to be $358,752,342,576, with the lowest SHC revenue forecast at $347,327,108,736, and the highest SHC revenue forecast at $374,747,669,952. On average, 12 Wall Street analysts forecast SHC's revenue for 2027 to be $378,746,501,796, with the lowest SHC revenue forecast at $365,893,113,726, and the highest SHC revenue forecast at $396,741,245,094.
In 2028, SHC is forecast to generate $400,454,446,092 in revenue, with the lowest revenue forecast at $387,029,796,330 and the highest revenue forecast at $418,163,558,544.